iShares國際國家輪換主動型ETF CORO 深 滬
已收盤 05-08 16:00:00 美东时间
35.89
+0.420
+1.18%
華盛通- 最 高35.98
- 今 開35.71
- 成交量 31.87万股
- 最 低 35.71
- 昨 收 35.47
- 總市值 374.19万
- 52周最高 36.5499
- 市盈率 靜 --
- 換手率 305.68%
- 52周最低 26.156
- 委 比 30.43%
- 總股本 0.00亿
- 歷史最高 36.5499
- 量 比 0.50
- 振 幅 0.76%
- 歷史最低 21.5447
- 每 手 1
- 風險率 2.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BlackRock iShares Sees Record $132 Billion Inflows As Bond ETFs, Active Strategies Surge In Q1
BlackRock's iShares drew a record $132B in Q1 inflows, fueled by surging demand for bond ETFs and rapidly growing active strategies.
04-16 00:54
iShares International Country Rotation Active ET declares $0.4891 dividend
iShares International Country Rotation Active ET (CORO) declares $0.4891/share semi-annual dividend. Payable Dec. 29; for shareholders of record Dec. 23; ex-div Dec. 23. See CORO Dividend Scorecard, Y...
2025-12-23 18:24
BRIEF-Philips To Buy SpectraWAVE To Advance AI-enabled Coronary Intravascular Imaging
Dec 15 (Reuters) - Koninklijke Philips NV PHG.AS: PHILIPS AGREES TO ACQUIRE SPECTRAWAVE INC., ADVANCING NEXT-GENERATION CORONARY INTRAVASCULAR IMAGING AND PHYSIOLOGICAL ASSESSMENT WITH AI ACQUISITION ...
2025-12-15 15:04
BRIEF-SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Oct 15 (Reuters) - SK Bioscience Co Ltd 302440.KS: SK BIOSCIENCE FILES FOR FIRST-IN-HUMAN TRIAL OF UNIVERSAL CORONAVIRUS VACCINE (PAN-SARBECOVIRUS VACCINE) GBP511 PHASE 1/2 STUDY IN AUSTRALIA SK BIOSC...
2025-10-15 20:03
BRIEF-Liberty Latin America Announces Retirement Of Eduardo Diaz Corona, SVP And General Manager Of Liberty Puerto Rico And Usvi
July 15 (Reuters) - Liberty Latin America Ltd LILA.O: LIBERTY LATIN AMERICA ANNOUNCES RETIREMENT OF EDUARDO DIAZ CORONA, SVP AND GENERAL MANAGER OF LIBERTY PUERTO RICO AND USVI Source text: ID:nBw2438...
2025-07-16 04:49
iShares International Country Rotation Active ET declares $0.2787 dividend
iShares International Country Rotation Active ET (NASDAQ:CORO) declares $0.2787/share semi-annual dividend. Payable July 8; for shareholders of record July 2; ex-div July 2. See CORO Dividend Scorecar...
2025-07-02 19:50
BRIEF-Artrya Ltd Submits FDA 510(K) Application For Salix Coronary Plaque Module
June 16 (Reuters) - Artrya Ltd AYA.AX: SUBMITS FDA 510(K) APPLICATION FOR SALIX CORONARY PLAQUE MODULE Further company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))
2025-06-16 09:29
BRIEF-Artrya Secures FDA Clearance For Salix Coronary Anatomy
March 28 (Reuters) - Artrya Ltd AYA.AX: SECURES FDA CLEARANCE FOR SALIX CORONARY ANATOMY Further company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))
2025-03-28 09:14
